Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-02 @ 4:03 AM
Study NCT ID:
NCT02318693
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2014-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-12
First Submit QC Date:
None
Study First Post Date:
2014-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-21
Results First Submit QC Date:
None
Results First Post Date:
2017-01-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-23
Last Update Post Date:
2018-08-21
Last Update Post Date Type:
ACTUAL